Patents by Inventor Nathan Robert AUGSPURGER

Nathan Robert AUGSPURGER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12478080
    Abstract: The present invention is directed to direct-fed microbials for use in improving the performance of an animal, improving the health of an animal, improving the environment of an animal, and combinations thereof. More particularly, the invention relates to isolated Bacillus strains 86 and 300, and strains having all of the identifying characteristics of these strains, for uses comprising the above-mentioned uses.
    Type: Grant
    Filed: December 22, 2020
    Date of Patent: November 25, 2025
    Assignee: MICROBIAL DISCOVERY GROUP, LLC
    Inventors: Michael R. King, Sona Son, Nathan Robert Augspurger, Joel Dean Spencer, Amy Lange, Michael D. Engelhardt
  • Patent number: 12390497
    Abstract: The invention relates to compositions comprising microbial strains for use in inhibiting viruses, and methods therefor. More particularly, the invention relates to compositions of isolated Bacillus strains selected from the group consisting of isolated Bacillus strains 300, 86, 101, 235, 102, 177, A12, 54, 681, 721, strains having all of the identifying characteristics of these strains, and combinations thereof, and methods for use of these strains for virus inhibition.
    Type: Grant
    Filed: March 19, 2020
    Date of Patent: August 19, 2025
    Assignees: MICROBIAL DISCOVERY GROUP, LLC, UNITED ANIMAL HEALTH, INC.
    Inventors: Michael R. King, Sona Son, Nathan Robert Augspurger, Joel Dean Spencer, Kyle Leistikow
  • Patent number: 11998576
    Abstract: The invention relates to direct-fed microbials for use in E. coli inhibition in animals. More particularly, the invention relates to isolated Bacillus strains 101, 235, 77, 177, and 102 and strains having all of the identifying characteristics of these strains, for a use comprising the above-mentioned use. The invention can also be used for treatment of plants and in food processing.
    Type: Grant
    Filed: August 16, 2021
    Date of Patent: June 4, 2024
    Assignees: MICROBIAL DISCOVERY GROUP, LLC, UNITED ANIMAL HEALTH, INC.
    Inventors: Michael R. King, Sona Son, Kyle Leistikow, Nathan Robert Augspurger
  • Publication number: 20220241352
    Abstract: The invention relates to direct-fed microbials for use in E. coli inhibition in animals. More particularly, the invention relates to isolated Bacillus strains 101, 235, 77, 177, and 102 and strains having all of the identifying characteristics of these strains, for a use comprising the above-mentioned use. The invention can also be used for treatment of plants and in food processing.
    Type: Application
    Filed: August 16, 2021
    Publication date: August 4, 2022
    Inventors: Michael R. KING, Sona SON, Kyle LEISTIKOW, Nathan Robert AUGSPURGER
  • Publication number: 20220143109
    Abstract: The invention relates to compositions comprising microbial strains for use in inhibiting viruses, and methods therefor. More particularly, the invention relates to compositions of isolated Bacillus strains selected from the group consisting of isolated Bacillus strains 300, 86, 101, 235, 102, 177, A12, 54, 681, 721, strains having all of the identifying characteristics of these strains, and combinations thereof, and methods for use of these strains for virus inhibition.
    Type: Application
    Filed: March 19, 2020
    Publication date: May 12, 2022
    Inventors: Michael R. KING, Sona SON, Nathan Robert AUGSPURGER, Joel Dean SPENCER, Kyle LEISTIKOW
  • Publication number: 20210360945
    Abstract: The present invention is directed to direct-fed microbials for use in improving the performance of an animal, improving the health of an animal, improving the environment of an animal, and combinations thereof. More particularly, the invention relates to isolated Bacillus strains 86 and 300, and strains having all of the identifying characteristics of these strains, for uses comprising the above-mentioned uses.
    Type: Application
    Filed: December 22, 2020
    Publication date: November 25, 2021
    Inventors: Michael R. King, Sona Son, Nathan Robert Augspurger, Joel Dean Spencer, Amy Lange, Michael D. Engelhardt
  • Patent number: 11110134
    Abstract: The invention relates to direct-fed microbials for use in E. coli inhibition in animals. More particularly, the invention relates to isolated Bacillus strains 101, 235, 77, 177, and 102 and strains having all of the identifying characteristics of these strains, for a use comprising the above-mentioned use. The invention can also be used for treatment of plants and in food processing.
    Type: Grant
    Filed: June 27, 2019
    Date of Patent: September 7, 2021
    Assignees: Microbial Discovery Group, LLC, United Animal Health, Inc.
    Inventors: Michael R. King, Sona Son, Kyle Leistikow, Nathan Robert Augspurger
  • Patent number: 10905135
    Abstract: The present invention is directed to direct-fed microbials for use in improving the performance of an animal, improving the health of an animal, improving the environment of an animal, and combinations thereof. More particularly, the invention relates to isolated Bacillus strains 86 and 300, and strains having all of the identifying characteristics of these strains, for uses comprising the above-mentioned uses.
    Type: Grant
    Filed: October 3, 2019
    Date of Patent: February 2, 2021
    Assignee: Microbial Discovery Group, LLC
    Inventors: Michael R. King, Sona Son, Nathan Robert Augspurger, Joel Dean Spencer, Amy Lange, Michael D. Engelhardt
  • Publication number: 20200029592
    Abstract: The present invention is directed to direct-fed microbials for use in improving the performance of an animal, improving the health of an animal, improving the environment of an animal, and combinations thereof. More particularly, the invention relates to isolated Bacillus strains 86 and 300, and strains having all of the identifying characteristics of these strains, for uses comprising the above-mentioned uses.
    Type: Application
    Filed: October 3, 2019
    Publication date: January 30, 2020
    Inventors: Michael R. King, Sona Son, Nathan Robert Augspurger, Joel Dean Spencer, Amy Lange, Michael D. Engelhardt
  • Publication number: 20200016217
    Abstract: The invention relates to direct-fed microbials for use in E. coli inhibition in animals. More particularly, the invention relates to isolated Bacillus strains 101, 235, 77, 177, and 102 and strains having all of the identifying characteristics of these strains, for a use comprising the above-mentioned use. The invention can also be used for treatment of plants and in food processing.
    Type: Application
    Filed: June 27, 2019
    Publication date: January 16, 2020
    Inventors: Michael R. King, Sona SON, Kyle Leistikow, Nathan Robert Augspurger
  • Publication number: 20200015497
    Abstract: The present invention is directed to direct-fed microbials for use in improving the performance of an animal, improving the health of an animal, improving the environment of an animal, and combinations thereof. More particularly, the invention relates to isolated Bacillus strains 86 and 300, and strains having all of the identifying characteristics of these strains, for uses comprising the above-mentioned uses.
    Type: Application
    Filed: June 27, 2019
    Publication date: January 16, 2020
    Inventors: Michael R. King, Sona Son, Nathan Robert Augspurger, Joel Dean Spencer, Amy Lange, Michael D. Engelhardt
  • Patent number: 10357046
    Abstract: The present invention is directed to direct-fed microbials for use in improving the performance of an animal, improving the health of an animal, improving the environment of an animal, and combinations thereof. More particularly, the invention relates to isolated Bacillus strains 86 and 300, and strains having all of the identifying characteristics of these strains, for uses comprising the above-mentioned uses.
    Type: Grant
    Filed: May 13, 2015
    Date of Patent: July 23, 2019
    Assignee: Microbial Discovery Group, LLC
    Inventors: Michael R. King, Sona Son, Nathan Robert Augspurger, Joel Dean Spencer, Amy Lange, Michael D. Engelhardt
  • Patent number: 10335440
    Abstract: The invention relates to direct-fed microbials for use in E. coli inhibition in animals. More particularly, the invention relates to isolated Bacillus strains 101, 235, 77, 177, and 102 and strains having all of the identifying characteristics of these strains, for a use comprising the above-mentioned use. The invention can also be used for treatment of plants and in food processing.
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: July 2, 2019
    Assignees: Microbial Discovery Group, LLC, United Animal Health, Inc.
    Inventors: Michael R. King, Sona Son, Kyle Leistikow, Nathan Robert Augspurger
  • Publication number: 20170246224
    Abstract: The invention relates to direct-fed microbials for use in E. coli inhibition in animals. More particularly, the invention relates to isolated Bacillus strains 101, 235, 77, 177, and 102 and strains having all of the identifying characteristics of these strains, for a use comprising the above-mentioned use. The invention can also be used for treatment of plants and in food processing.
    Type: Application
    Filed: February 28, 2017
    Publication date: August 31, 2017
    Inventors: Michael R. KING, Sona SON, Kyle LEISTIKOW, Nathan Robert AUGSPURGER
  • Publication number: 20170079308
    Abstract: The present invention is directed to direct-fed microbials for use in improving the performance of an animal, improving the health of an animal, improving the environment of an animal, and combinations thereof. More particularly, the invention relates to isolated Bacillus strains 86 and 300, and strains having all of the identifying characteristics of these strains, for uses comprising the above-mentioned uses.
    Type: Application
    Filed: May 13, 2015
    Publication date: March 23, 2017
    Applicant: MICROBIAL DISCOVERY GROUP, LLC
    Inventors: Michael R. KING, Sona SON, Nathan Robert AUGSPURGER, Joel Dean SPENCER, Amy LANGE, Michael D. ENGLEHARDT